April, 2017 - BioGX

BioGX Product Catalogs

BioGX Product Catalogs

BioGX Product Catalogs

Title	Size	Download
BioGX Product Catalog_Rev. 1.5_13AUG2024	5.37 MB	Download Preview
BioGX Multi-Platform Product Catalog_Rev1.4_13AUG2024	3.65 MB	Download Preview
BioGX BD MAX Product Catalog_Rev0.3_13AUG2024	4.40 MB	Download Preview

Robert Martinez, Ph.D, VP, Business Development & Scientific Affairs

Dr. Martinez joined BioGX in 2015. Dr. Martinez is responsible for Business Development and Scientific Affairs, expanding our portfolio of IVD products, managing the global technical support efforts of all molecular diagnostic products, and manages a team of scientists responsible for product and technology innovation in conjunction with existing corporate partnerships. Dr. Martinez has over 20 years of experience in molecular biology. Prior to joining BioGX, Dr. Martinez held research positions focusing on cancer cell biology at Albany Medical College, microbial community dynamics at The Georgia Institute of Technology and microbial physiology at The University of Alabama. Dr. Martinez holds a BA in Biology from Boston University and a Ph.D. in Microbiology from The Georgia Institute of Technology.

Hardy Green, Controller

Mr. Green joined BioGX as a Controller in 2020. He has 30+ years of leadership experience in accounting across diverse industries, including healthcare, water utility management, waste management, mineral extraction, and cash handling. At BioGX, Mr. Green is responsible for managing finance and purchasing departments. He has a BS degree in Accounting from The University of Alabama, and he is a Certified Public Accountant (inactive).

Shazi Iqbal, Ph.D, Venture Partner

Dr. Shazi Iqbal is a Co-Founder of BioGX and served as its CEO from 2011 to June 2024. Now, as a Venture Partner, he leads M&A and strategic investment opportunities to enable innovation partnerships. Dr. Iqbal has over 25+ years of experience in building healthcare startups into profitable growth companies. He holds a Ph.D. in Biology (Neuroscience), two M.S. degrees in Biochemistry & Biotechnology, and several patents and publications.

Run Files

Download

Download Here

Targets

Bacteria

Viruses

Acinetobacter baumannii

Bacteroides fragilis

Chlamydia trachomatis

Citrobacter freundii

Citrobacter koseri

Clostridium novyi/Clostridium septicum

Clostridium perfringens

Enterobacter spp.

Enterobacter cloacae complex

Enterococcus faecalis

Enterococcus faecium

Enterococcus spp. (Enterococcus faecalis, Enterococcus faecium)

Escherichia coli

Gardnerella vaginalis

Haemophilus ducreyi

Kingella kingae

Klebsiella aerogenes

Klebsiella oxytoca

Klebsiella pneumoniae

Klebsiella spp. (Klebsiella oxytoca, Klebsiella pneumoniae)

Morganella morganii

Mycoplasma genitalium

Mycoplasma hominis

Neisseria gonorrhoeae

Proteus mirabilis

Proteus spp. (Proteus mirabilis, Proteus vulgaris)

Proteus vulgaris

Providencia stuartii

Pseudomonas aeruginosa

Salmonella spp.

Serratia marcescens

Staphylococcus aureus

Staphylococcus epidermidis

Staphylococcus epidermidis group (S. hominis ,S. simulans, S.warneri, S. epidermidis, S. haemolyticus)

Staphylococcus haemolyticus

Staphylococcus lugdunensis

Staphylococcus saprophyticus

Streptococcus agalactiae

Streptococcus pyogenes

Treponema pallidum

Ureaplasma parvum

Ureaplasma urealyticum

HSV-1

HSV-2

Fungi
Candida albicans
Candida auris
Candida glabrata
Candida krusei
Candida parapsilosis
Candida spp. (C.albicans, C. auris, C. dubliniensis, C. glabrata, C. krusei, C.lusitaniae, C. parapsilosis, C. tropicalis)
Candida tropicalis

Protozoan
Trichomonas vaginalis

Antimicrobial Resistance
GES
KPC
mcr-1
mecA
mecC
NDM
OXA-48
van B
vanA
vanC1/C2/C3
VIM

SAMPLE-TO-ANSWER IN 3 EASY STEPS!

Shahin Iqbal, Ph.D, President and COO

Dr. Shahin Iqbal is the President and Chief Operating Officer at BioGX. He has over 25 years of experience in clinical molecular diagnostics. Before joining BioGX, Dr. Iqbal led the Abbott Diagnostics Global Service & Support specifically for informatics, core lab automation, immunoassay and clinical chemistry systems. He was also responsible for design and development of FISH automation systems at Abbott Molecular. He is the recipient of the President awards and multiple service & innovation awards at Abbott. Dr. Iqbal holds multiple patents on optical sensors, automation systems development, RFID applications and robotics for system dispensing. Prior to joining Abbott, Dr. Iqbal was Head of operations, quality & regulatory, systems development and manufacturing of IHC systems at BioGenex in California. Dr. Iqbal has an MBA and Ph.D as well as a Masters in Electrical Engineering degree from the University of Texas in San Antonio.

George Blackstone, VP, Research & Development

Mr. Blackstone joined BioGX in 2007. He has served at BioGX in various senior R&D and quality management roles prior to his current position as VP of Research & Development. Mr. Blackstone has designed and directed the development of over 100 multiplex real time PCR products in the fields of food safety, water quality, pharma QC, and clinical diagnostics. Mr. Blackstone previously served for eight years at the US Food and Drug Administration and as a Commissioned Research Officer in the US Public Health Service Commissioned Corps where he achieved the rank of Lieutenant Commander. George Blackstone received his Master of Science degree from Louisiana State University.

Christopher Hughes, VP, Operations & QRA

Mr. Hughes joined BioGX in 2015. Prior to joining BioGX, Mr. Hughes led efforts for a diverse range of companies with the development and implementation of certified quality management systems ranging from data storage devices with SONY Corporation, security & detention devices with Norment Security Group, textile manufacturing with Twitchell Corporation, combat vehicle manufacturing with General Dynamics, and therapeutic medical devices with Steris Corporation. Christopher has a BSE from Auburn University and an MBA from Troy State University.

Please read this

If you are contacting us because you have received a phone call offering genetic testing services, with the caller requesting personal health information and personal identification numbers (such as Medicare Card numbers), please know that we are NOT responsible for such calls.

We, BioGX, Inc., (registered trademark “BioGX”) with offices in Birmingham, AL, Dallas, TX, and Amsterdam, The Netherlands, are a diagnostic test manufacturer and not a testing laboratory, and we are not in any way affiliated with such callers. We do not know who is making these calls.

UNDER NO CIRCUMSTANCES BIOGX WOULD EVER CONTACT INDIVIDUALS TO OFFER GENETIC TESTING SERVICES OR REQUEST PERSONAL INFORMATION OF ANY KIND.

EUO Label Instructions

Download all

Emergency Use Only (EUO) Instrument Label

Emergency Use Only (EUO) Instrument Label

Title	Download
QuantStudio™5 - EUO Label Instructions	Download Preview
EUO Instrument Label	Download Preview
Bio-Rad CFX384 Touch™ EUO Label Instructions	Download Preview
Bio-Rad CFX96 Touch™ EUO Label Instructions	Download Preview
ABI 7500 Fast Dx - EUO Label Instructions	Download Preview

testing-button

Xfree™ COVID-19 Flyer – Single Sample Testing

View Here

Xfree™ COVID-19 Flyer – Pooled Sample Testing

View Here

Fact Sheets

This Fact Sheet informs you of the significant known and potential risks and benefits of the use of the BioGX Xfree™ COVID-19 Direct RT-PCR.

The BioGX Xfree™ COVID-19 Direct RT-PCR is validated for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.

Healthcare Provider Fact Sheet

Patient Fact Sheet

Download Here

Xfree™ COVID-19 IFU and Run Reports

Please complete the form below and our Product Support Team will be in touch with you shortly.

Xfree™ COVID-19 Direct RT-PCR Clinical Concordance Study

Download Here

Download the required Direct Sample Run Files and associated PDFs

QuantStudio™ 5

QuantStudio™ 5 Direct Sample Run File

QuantStudio™ 5 Direct Sample PDF

CFX96 Touch™

CFX96 Touch™ Direct Sample Run File 1

CFX96 Touch™ Direct Sample Run File 2

CFX96 Touch™ Direct Sample PDF

Michael Vickery, PhD, EVP, Chief Scientific Officer

Dr. Vickery founded BioGX in 2007 and served as President and CEO until 2011. Prior to founding BioGX, Dr. Vickery worked in sales and as a technical consultant at Cepheid. Prior to Cepheid, Dr. Vickery worked at the FDA as a University of Maryland JIFSAN postdoctoral fellow at the University of Maryland, and later served as the Lead for Molecular Methods Development at the U.S. FDA Gulf Coast Seafood Laboratory. He holds multiple patents in biotechnology, has authored or co-authored many publications, and has extensive experience in gene expression analysis, and in the design and development of rapid multiplex molecular tests for microbial and viral detection. Dr. Vickery holds a B.S. degree in Physics and both M.S. and Ph.D. degrees in Biology (molecular biology and molecular genetics focus – both prokaryotic and eukaryotic). Prior to entering graduate school, Dr. Vickery worked as an executive in the lowbed trailer industry for almost 10 years, pioneering the sale of American made heavy equipment transport trailers into China (ROC) and Japan during his tenure in the industry, and resupplying the oilfields of Kuwait with specialized trailers after the Gulf War.

Breaking News: BioGX Expands PCR Test Menu at State Departments of Health Read More

BioGX Launches Four CE-Marked IVD Assays At The European Congress Of Clinical Microbiology And Infectious Diseases (ECCMID)

Announcing The Establishment Of BioGX EU

COMPANY

RESOURCES

Products

FOLLOW BIOGX

Stay up to date

BioGX Product Catalogs

Targets

Emergency Use Only (EUO) Instrument Label